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Abstract
Purpose Cancer survivorship care plans (SCPs) are currently
used in care settings to assist survivors during the transition
from treatment to survivorship. In this paper, the experiences
of cancer survivors are examined to provide their perspective
of how survivorship care plans are used in practice.
Methods A systematic review and critical review of the qual-
itative literature regarding the experiences of cancer survivors
using survivorship care plans was completed. Databases
reviewed included CINAHL, AMED, Embase, MEDLINE,
Informit, ProQuest, PsycINFO, ScienceDirect, Wiley Online
Library, Scopus and Web of Science from 2000 to 2014.
Results Eleven qualitative studies were appraised for method-
ological quality and content. They revealed four key themes:
stakeholders agreed that SCPs should be used as a key strategy
for cancer survivors; there was a lack of consensus on the
format, content and who should develop the SCP; cancer
survivors do not consistently receive SCPs; and there was a
lack of evidence to support the use of SCPs in practice.
Conclusions There is great potential for SCPs to assist cancer
survivors and this is supported by the range of qualitative
literature examined in this study. Further research is required
to examine the many practical issues relating to the delivery of
SCPs and how they may be used across a variety of care
contexts as well as providing further evidence to support their
use.
Implications for Cancer Survivors With further research, re-
finement and contributions made by survivors, health re-
searchers and health care professionals, the survivorship care
plan is proposed to be a useful and practical tool aimed at
supporting the survivorship continuum of care.
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Introduction
The proportion of people surviving cancer is increasing in
many parts of the world due, in part, to early diagnosis,
increased rates of detection and significant improvements in
treatment [1–3]. However, many cancer survivors experience
a range of ongoing difficulties related to the disease itself and
the treatments used. These difficulties continue to impact upon
survivors during, immediately after and, for some individuals,
many years after completion of their treatment [4–6]. Well-
recognised physical problems include chronic pain, weight
gain, osteoporosis, premature menopause and memory and
sleep disturbances. Additional consequences of cancer and
cancer treatments can contribute to further difficulties includ-
ing a range of chronic health conditions including heart dis-
ease and diabetes [7]. Psychological difficulties including
depression and anxiety may also be experienced, and these
may be associated with ongoing symptoms of fatigue, sexual
dysfunction, fear of recurrence and changes to relationships
[8, 9]. A recent Australian study identified that long-term
survivors of cancer reported increased levels of vulnerability,
loneliness and anxiety about their health and the possibility of
the cancer returning [10]. It is evident that many cancer
survivors experience significant ongoing problems with re-
suming their usual roles and relationships as well as returning
to their previous routines and habits.
There are many less-recognised and sparsely publicised
issues for survivors following cessation of treatment including
social difficulties, maladjustment to work responsibilities,
intimacy problems, organisational difficulties and cognitive
processing issues [11–13]. The literature also identifies a
range of existential problems affecting cancer survivors
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including challenges pertaining to self-identity and personal
expectations [14]. Globally, survivors are increasingly seeking
a wider range of supports and services during the post-
treatment period to assist them with the breadth of physical
and psychological difficulties experienced in the longer term
[13, 15, 16]. In most developed countries, a range of strategies
are currently available to assist cancer survivors with these
ongoing difficulties, including access to health services, sup-
port groups, online forums and educational tools. However, it
appears that there is a lack of recognition of this period with
referral and coordination for follow-up care needed during
cancer survivorship [6].
The Survivorship care plan (SCP) is postulated as a poten-
tial resource to improve survivorship care. The SCP is
recognised as an important tool that may be used during the
survivorship period and one which is attracting further re-
search in the international context because of its potential to
assist survivors to direct and navigate their own ongoing care
[8, 10, 13, 17–19].
Use of survivorship care plans across the world
Researchers in the United States of America (USA),
Canada and the United Kingdom (UK) have made sig-
nificant contributions to the study of the survivorship
phenomenon [4]. In 2005, the Institute of Medicine
(IOM) (USA) published its report ‘From cancer patient
to cancer survivor: lost in transition’ [8]. This report
outlined key recommendations to assist cancer survivors
in the longer term including the use of SCPs. The SCP
usually includes a summary of diagnosis and treatment,
methods of surveillance for the potential development of
malignancies, maintenance of healthy lifestyle, legal and
financial rights and identification of support services
[20]. These recommendations have been widely accept-
ed in many countries as critical to the care of survivors
yet have not been fully evaluated. In a randomised
control trial conducted by Grundfeld [21], it was found
that there was little evidence to support the use of the
SCP in practice. However, this study was limited to
survivors of breast cancer and its generalisability to
other types of cancer, as well as the context of care,
has not been investigated [22].
Canada has had a national cancer strategy since 2007
which identifies key priorities for survivorship: the develop-
ment and implementation of national standards and models of
care; promotion of survivorship research, knowledge and
communication plans and advocacy groups; and an emerging
interest in the use of SCPs [23]. In the UK, the National
Cancer Survivorship Initiative (NCSI) articulates the care of
survivors using a recovery-focussed, personalised approach
with explicit outcome measures to determine the effectiveness
of the services provided. It recommends that all survivors are
offered a treatment summary and care plan as well as appro-
priate education and information [4].
Australia does not have a national cancer plan or con-
sistent model of care for cancer survivors. Models of care
across the states of Australia vary and include the disease-
specific model, general survivorship model, consultative
clinic, multidisciplinary clinic, integrated care model and
transition to primary care model [24]. This has resulted in
each state providing a different framework of care, a
variety of practice guidelines and a range of state-based
services. According to one Australian author, Jefford et al.
[4], the ‘traditional’ medical follow-up currently offered
may not meet survivors’ needs due to its focus on cancer
recurrence and not on other important, but less obvious,
concerns. The SCP which offers a summary of treatment,
surveillance and recommendations for follow-up care is a
key resource used in many other countries, however, to
date, not used consistently in Australia and other
countries.
There is a range of published literature that explores the use
of SCPs in many different countries and contexts of care with
sources of input from oncologists, primary care physicians/
general practitioners and oncology nurses. More recently,
systematic reviews of the quantitative literature have been
conducted that consider a range of issues including survivor-
ship models of care [25] and the effectiveness of the SCP [3].
While these studies contribute to the range and breadth of the
literature, there has been very little consideration of survivors’
own perspectives regarding their experiences and views about
the use of the SCP [20, 26, 27]. As SCPs are used by a range of
health professionals, it is essential that the preferences of
survivors, as key stakeholders in the continuum of care, are
explored and articulated to ensure services and supports are
directed appropriately.
The aim of this systematic review is to document and
review the available published qualitative literature that de-
scribes cancer survivors’ experiences of using survivorship
care plans.
Methods
An examination of existing published systematic reviews and
protocols was undertaken to determine whether the research
question was appropriate due to previously published litera-
ture on the subject. The following sources were initially
reviewed: Cochrane Collaboration, Joanna Briggs Institute,
Database of Abstracts of Reviews of Effects (DARE),
PROSPERO and Trip. It was established that no existing
systematic reviews of the research question had been regis-
tered or published to date.
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Search strategy and data sources
A protocol for searching was established prior to commence-
ment of the search. Priori inclusion criteria were determined as
follows: adults only (18 years and above), date range from
2000 to 2014 and published in English. Publications were
excluded if they reported on the experience of cancer treat-
ment or the palliative phase of care and were conference
presentations or abstracts only. Searches of electronic data-
bases completed were CINAHL, AMED, Embase,
MEDLINE, Informit, ProQuest, PsycINFO, ScienceDirect,
Wiley Online Library, Scopus and Web of Science. The
Journal of Cancer Survivorship was also reviewed for publi-
cations that met the inclusion criteria. Permutations of the
following search terms were truncated and exploded: cancer,
neoplasm or malignancy survivor, experiences, opinions,
ideas, views or preferences, survivorship care plan, post-
treatment care, forward care, survivorship program,
individualised care plan and comprehensive care plan.
The searches identified a total of 428 records using the
search terms above. Hand searching of reference lists identi-
fied an additional 12 articles for review. Thirty five records
were excluded as duplicates. The title and abstracts of the
remaining 405 records were reviewed by the first author and
46 of these met the prior inclusion criteria for full review. The
full-text articles were then reviewed independently by the first
and second authors using the eligibility criteria of any of the
following: qualitative studies including systematic reviews,
interviews, focus groups, case studies, descriptive studies,
observational and narrative studies; action research as well
as the qualitative components of mixed methods studies.
Additional eligibility criteria included survivors’ experiences
of using a SCP and analysis and discussion about the findings
of the study (refer to Fig. 1 for details of data screening). In
total, 11 papers were determined as eligible for critical ap-
praisal of methodological quality.
Data analysis
Critical appraisal of methodological quality was completed
using the ‘Standard Quality Assessment Criteria for
Evaluating Primary Research Papers from a Variety of
Fields’ by Kmet, Lee and Cook [28]. This tool uses a numeric
score (0–2) to rate the quality of ten categories considered
essential to the research credibility. The categories assessed
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Fig. 1 Data screening flow chart
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are as follows: research question or objective stated clearly,
explanation of the study design, context clearly defined, con-
nection to a theoretical framework, justification of the sam-
pling strategy, description of data collection, clearly defined
analysis of results, use of verification procedures discussed,
conclusions drawn and reflexivity of authors considered. The
first two listed authors independently assessed each paper
using these criteria to determine a total score out of a possible
20. Where there was a difference in scores of greater than
1/20, discussion and consensus agreement was reached. The
calculated scores were defined according to quality as strong
(score of >80 %), good (70–80 %), adequate (50–70 %) or
limited (<50 %). Studies were included if they received a
quality score of 70 % and above. All of the 11 studies
reviewed met the minimum requirement of 70 % on the
assessment criteria. A list of each study’s scores using the
appraisal tool can be found in Table 1. The total number of
participants included across all reviewed studies was 336 with
one study not stating the number of participants.
Summary of results
The 11 studies included the use of interviews (four studies),
focus groups (six studies) and action research (one study).
Table 1 provides a comprehensive summary of each study
including sample location, population, number of participants,
gender, age range, cancer type, time since diagnosis, time
since completion of treatment and marital/partnership status.
A content analysis was undertaken to review and understand
the breadth and depth of the themes discussed for each of the
studies by each of the researchers [40]. These themes were
discussed and refined and are presented as follows.
Data analysis and synthesis of results
Four significant themes were identified following content
analysis of the 11 articles: (1) stakeholders agree that SCPs
should be used as a key strategy for cancer survivors; (2) lack
of consensus on what the SCP should contain and who should
develop it; (3) cancer survivors do not consistently receive a
SCP and (4) there was a lack of evidence to support the use of
SCP in practice.
Stakeholders agreed that SCPs should be used as a key
strategy for cancer survivors
The SCPs were identified as a key strategy during the post-
treatment period for cancer survivors [29–39] by the authors
of all studies. Significant points raised by researchers include
the use of SCPs to reduce duplication of materials improved
coordination of care and increased communication between
health professionals and cancer survivors. Specific areas for
improvement were that the SCP needed to be accessible and
nontechnical and directed to address the cultural issues spe-
cific to particular groups of people.
A significant finding from the majority of authors [28, 30,
31, 34–37] was the recommendation that SCPs should be
targeted to provide coordinated, individualised and patient-
centred care. This was also the expectation of cancer survi-
vors. There appeared to be many barriers preventing this
occurring in practice due to the limitations of the time needed
to complete them, the need for resources and a lack of training
on how to complete them [30–32, 35, 36, 40].
The use of SCPs assisted cancer survivors to translate
information from specialist providers to their primary care
providers and gave direction for the future [31, 32, 34, 35,
39]. It was also noted that SCPs reduced duplication of infor-
mation and helped to synthesise treatment information to
provide patients with peace of mind, a written synopsis of
treatment and a targeted surveillance strategy during follow-
up [34, 38, 39]. Furthermore, a range of unique survivorship
issues relating to cultural background were identified, and
many authors stated the importance of considering these
broader issues as part of the development of the SCP [29,
32, 35]. Ashing-Giwa et al. [29] and Burg et al. [32] noted the
explicit concerns of African-American women survivors of
breast cancer and discussed the importance of including re-
sources to address questions regarding treatment-related skin
pigment changes and the availability of genetic testing for
family members. Singh Carlson et al. [38] noted concerns
raised in their study regarding South Asian women living in
Canada, including the significance of family relationships and
importance of faith during and after the treatment period.
The use of patient-centred SCPs was thought to assist in the
transition from treatment to survivorship but also needed to be
used in conjunction with suitable models of care [31, 34, 37].
Many different models are used by cancer survivors including
shared care, consultative care, the chronic illness model and
transitional care which resulted in the use of a range of tools
and strategies as well as the involvement of many health
professionals. At times, the complexities of these models
resulted in a breakdown in communication and coordination
of care. Several authors commented that SCPs could be used
as a resource to facilitate well-timed support and case coordi-
nation [32, 34, 36, 39].
Lack of consensus on what the SCP should contain, what
format it should follow and who should develop it
The studies provided a range of findings regarding three
important issues: what to include in the SCP, the format of
the SCP and who should be responsible for developing it.
Four studies indicated the essential components of the SCP






















































































































































































































































































































































































































































































































































































































































































































































































































































treatment and signs and symptoms of recurrence [30, 32, 38,
39]. Two studies [34, 38] concluded that SCPs must not only
consist of a generic template of key considerations but also
include sections for personalised items relating specifically to
the individual. These additional items included educational
resources regarding lifestyle changes, nutrition, exercise and
details of support organisations.
One author, Faul et al. [33], stipulated the need for SCPs to
include a ‘designated key provider’ to assist with the transition
between care environments and services. This was supported
by Brennan et al. [31], who reported that the SCP could be
used to improve care and coordination of key stakeholders
during the survivorship period. Marbach et al. [36] indicated
that an overview of late and long-term effects also needed to
be included as well as referrals for health professional
services.
A significant finding from ten of the 11 reviewed studies
was that currently, SCPs do not identify or address the signif-
icant psychosocial needs reported by cancer survivors [29–32,
34–39]. Both Burg et al. and Kantisper et al. reported that the
breast cancer survivors in their studies had specific concerns
regarding the need for assistance regarding an altered body
image, breast reconstruction issues and weight gain [32, 35].
Depression, fear of recurrence and difficulties with relation-
ships, intimacy and sexual function were described by Singh-
Carlson et al. [38]. A ‘sense of abandonment’ as survivors
transitioned from the treatment phase to survivorship was also
discussed by Parry et al. [37] and Burg et al. [32] who
explained this period as being pivotal for the adjustment
between these two periods. This period of transition was also
commented on by Singh-Carlson et al. [38] who identified
many uncertainties regarding returning to work as well as
concerns about the future to be included and examined as
key elements of the SCP. What was common to all these
authors was the potential for the SCP to identify particular
psychosocial concerns as well as provide resources and sup-
ports that could be used by survivors and health professionals
in the longer term.
Interestingly, Baravelli et al. [30] reported that the use of
the SCP may also cause some distress to some survivors
particularly when information regarding the recurrence of
cancer was highlighted. This is a key point of interest for all
people involved in the development of the SCP and one which
warrants further exploration.
Several ideas regarding the most suitable format for the
SCP were raised. Singh Carlson et al. [37] stressed the need
for the SCP to be written in a language suitable for the
population group and presented as a written, portable docu-
ment so that survivors could use it as a key resource when
negotiating new services or engaging other health profes-
sionals. Other studies indicated the need for a ‘living’ docu-
ment available in electronic format [33, 35] which could be
modified and readily available to all stakeholders.
There were varied views regarding who was most suited to
develop the SCP. The primary care physician (PCP) or general
practitioner (GP) was identified as suitable [29, 32, 34, 39], as
were the oncology or specialist provider [33] and oncology
nurse [36]. Other studies did not reach a clear consensus about
who should take primary responsibility for this [30, 31, 38].
Only three studies stressed the need for survivors themselves
to be included in the development of their own SCP
[29, 36, 37].
Many studies identified a range of barriers associated with
incorporating the SCP into their current model of practice
including a lack of training available to assist health profes-
sionals to prepare these [31, 32, 34, 35] and the time required
to develop and prepare SCPs [29, 32–34, 38]. Also noted by
Faul et al. [33] and Hewitt et al. [34] was the uncertainty
regarding responsibility for the cost of developing SCPs with
many models of care not providing financial assistance for
these additional resources.
Cancer survivors do not consistently receive the SCP
There was a wide range of findings regarding availability and
access to SCPs. Ashing-Giwa et al. [29] reported that only one
of the 25 participants in their study had received a SCP. Other
authors [34, 36] reported that ‘few to some’ had accessed the
resource. Only one of all the reviewed studies [33] indicated a
consistent provision of the SCP as part of the cancer survivor-
ship period. Baravelli et al. [30] indicated that only one quarter
of cancer survivors in their study received a written statement
of any type regarding diagnosis. Ten percent had received a
treatment summary and 15 % had received copies of diagnos-
tic tests. While this information was recognised as important
components of SCPs, it was also acknowledged that there was
very little information provided regarding what to expect in
the future such as long-term effects of treatment, potential
psychosocial concerns and resources for ongoing problems.
Four studies [31, 32, 37, 38] reported that this issue may be
related to the varying models of practice, inconsistencies
around the coordination of survivorship care and a lack of
consensus regarding the most appropriate time to provide the
SCP to survivors.
Lack of evidence to support the use of SCP in practice
Adding to the potential reasons for why SCPs are not used
routinely is the lack of clear evidence to support the use of the
SCP in clinical practice. Recommendations were made by all
authors regarding the need to conduct both qualitative and
quantitative studies regarding the efficacy and application of
SCPs in the future. Of considerable interest was the essential
research needed to determine the opinions and preferences of
cancer survivors themselves contributing to the research dia-
logue concerning SCPs [30, 34]. Two studies [33, 37]
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indicated a dearth of research regarding whether SCPs result-
ed in improved care and outcomes for cancer survivors.
Additional statements by two authors [29, 32] stated that
prospective longitudinal studies were vital for determining
the long-term benefits and any added value of using SCPs as
part of the overall care of cancer survivors.
Further recommendations were made to suggest that both
qualitative and quantitative studies were needed to support if
and how the SCP could be integrated into standard oncology
care [33] and the health professionals best suited to provide
them [31, 35, 38]. Parry et al. [37] argued that research was
needed to evaluate each component of the SCP to substantiate
their use across the various contexts of use.
Discussion
This systematic review considered the range of data collected
by the authors of 11 studies, all contributing to the qualitative
evidence regarding the research question. According to the
Institute of Medicine [8], the purpose of a SCP is to include a
summary of cancer diagnosis and treatment, information re-
garding likely consequences of treatment and follow-up health
information. It should also document information regarding
health insurance, employment issues and psychosocial sup-
port. While the use of SCPs has varied amongst countries
including the USA, Canada, UK and Australia, the availability
and consistency of use is also not constant across the various
contexts of care. According to the studies reviewed, there are a
number of barriers and enablers influencing their acceptability
and integration into the various models of care.
A key concern is that the survivorship period requires
improved recognition as an integral period of the cancer
journey. The reviewed studies support other literature regard-
ing an emerging awareness and recognition of survivorship as
a distinct part of the cancer journey [13, 41, 42]. It is apparent
that health policies and the models of care that support cancer
survivors also require attention so as to consider the many
variables impacting this group of consumers [16, 24]. A
consistent approach to the delivery of supportive services to
cancer survivors, including the use of SCPs, is essential and
must be prioritised for the future [6, 26, 32, 37].
According to the IOM [8], SCPs have the potential to
empower and inform survivors about diagnosis and treatment,
monitoring required and follow-up care available as well as
act as a communication tool between stakeholders in order to
maximise health [26]. However, greater consultation is needed
between patients and the health professionals involved to
ensure that the SCP is individualised and reflects the key
concerns and issues for the cancer survivor. Cancer survivors
are frequently not included in the development of the SCP, and
therefore not targeted to the specific needs of individuals [3].
This is of particular concern as the need for consumers to be
involved and ‘in charge’ of their health care requirements is
regarded as an essential component of contemporary health
practice [13, 16].
Further considerations for the development of SCPs might
require adoption of a generic template with options for people
with specific types of cancer and particular population groups.
As noted by several authors, a much greater consideration of
the psychosocial concerns experienced by cancer survivors is
needed and included for discussion [9, 41, 43]. Some specific
concerns include sexuality, intimacy, mood and adjustment to
previous roles and relationships [6, 44, 45]. Additional edu-
cational information for financial, social, health and spiritual
supports may also be required [8, 18, 46].
Agreement on many of the practical issues regarding use of
the SCP is yet to be reached. Who is responsible for develop-
ing the SCP, what it should include and how it should be
developed are still unclear. Some potential reasons for this
may include time constraints, the cost of preparing the SCP
and a lack of rigid evaluation regarding the efficacy of these
[16, 18, 47, 48]. Also noted is the requirement to meet the
needs of specific population groups, e.g. African-American,
Southeast Asian and others with unique needs to address
issues relevant to these cancer survivors.
Finally, there has been a growing effort by researchers to
explore the effectiveness of SCPs for cancer survivors. In a
recent systematic review conducted by Martin et al. [3], it
concluded that while limited evidence existed regarding the
effectiveness of SCP for a group of breast cancer survivors,
the SCP did assist with the assessment and symptom manage-
ment of survivors in the longer term. In contrast, other re-
searchers concluded that the use of SCPs could assist health
professionals to determine strategies for surveillance, increase
communication amongst stakeholders and transition care from
a medical model to a wellness model [17, 18, 20].
Conclusion
This systematic review examined the experiences of cancer
survivors using survivorship care plans and explored many of
the current issues relating to their use across a range of
different contexts. While the period of cancer survivorship is
gaining interest amongst clinicians and researchers, it is clear
that further studies are needed to explore the range of SCPs
available, the practicalities related to their use and how to best
ensure they meet the needs of cancer survivors in the future.
Limitations
It is recognised that there are many published studies using
quantitative methodologies in the subject area of SCPs and
J Cancer Surviv
that these may offer additional data and discussion regarding
the topic. This review also targeted the use of SCPs from the
perspective of survivors and therefore the experiences of other
key stakeholders (treatingmedical professionals and providers
of support services) are not articulated.
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